You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增19.76万宗新冠确诊 纽约市疫苗短缺接种预约须延期
阿思达克 01-22 16:13
美国新冠数字缓和。据美国约翰霍普金斯大学统计,截至美国西岸时间午夜(本港时间下午4时),美国累计新冠确诊24,631,890宗,单日新增197,606宗。累计死亡个案410,349宗,单日新增4,348宗。各州疫情方面,加州累计确诊310万宗,德克萨斯州累计确诊220.89万宗,佛罗里达、纽约及伊利诺伊州各累计确诊161.39万、129.37万及108.63万宗。

纽约市警察及消防部门分别暂停为警员及消防员注射首剂疫苗,因疫苗供应紧张。纽约市宣布因当地疫苗短缺,即日至周日(24日)的疫苗注射预约需要改期至下周。对於美国纽约州州长科莫表示,要求可以直接向药厂订购新冠疫苗,药厂辉瑞(PFE.US)表示,有关要求须获美国政府签令批准。

以下为过去七日美国每日新冠疫情统计,截数时间为美国西岸时间午夜。

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

1月21日(四)│24,631,890宗│+197,606宗│410,349宗│+4,348宗

1月20日(三)│24,434,284宗│+180,146宗│406,001宗│+4,238宗

1月19日(二)│24,254,138宗│+175,366宗│401,763宗│+2,760宗

1月18日(一)│24,078,772宗│+141,997宗│399,003宗│+1,403宗

1月17日(日)│23,936,775宗│+182,403宗│397,600宗│+1,815宗

1月16日(六)│23,754,372宗│+223,909宗│395,785宗│+3,679宗

1月15日(五)│23,530,463宗│+217,360宗│392,106宗│+3,566宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account